Mean corpuscular hemoglobin predicts the length of hospital stay independent of severity classification in patients with acute pancreatitis
Abstract: Mean corpuscular hemoglobin (MCH) is a common blood routine test index. To explore the relationship between MCH and length of hospital stay in patients with acute pancreatitis (AP), we included 273 patients with AP without coronary heart disease, diabetes, hypertension and anemia in this study. All data were separated into three groups according to the length of hospital stay. Gender (p = 0.017) and severity classification (p < 0.001) were significantly correlated with length of hospital stay among three groups. Notably, MCH level was significant different among three groups (p = 0.009). Thus, all data were separated into two groups according to MCH level, and significant increases in the length of hospital stay were observed between two groups (p = 0.030). A positive correlation between length of hospital stay and MCH was observed (r = 0.172, p = 0.004). Multiple linear regression analysis showed that MCH was independent correlated with the length of hospital stay, no matter whether severity classification of AP was included (beta = 0.248, p < 0.001; beta = 0.212, p < 0.001). Our results demonstrated that the length of hospital stay was correlated with MCH level in patients with AP, and MCH level at admission may predict the length of hospital stay independent of severity classification in AP. These results may provide a potential evaluation basis for the management of patients with AP.
- Location
-
Deutsche Nationalbibliothek Frankfurt am Main
- Extent
-
Online-Ressource
- Language
-
Englisch
- Bibliographic citation
-
Mean corpuscular hemoglobin predicts the length of hospital stay independent of severity classification in patients with acute pancreatitis ; volume:17 ; number:1 ; year:2022 ; pages:1449-1454 ; extent:6
Open medicine ; 17, Heft 1 (2022), 1449-1454 (gesamt 6)
- Creator
-
Lin, Hao
Yu, Ting
Xu, Rong
Li, Xing
- DOI
-
10.1515/med-2022-0559
- URN
-
urn:nbn:de:101:1-2022090614065528447378
- Rights
-
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Last update
-
15.08.2025, 7:25 AM CEST
Data provider
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Associated
- Lin, Hao
- Yu, Ting
- Xu, Rong
- Li, Xing
Other Objects (12)
A genomics-based systems approach towards drug repositioning for rheumatoid arthritis
Large-scale mining disease comorbidity relationships from post-market drug adverse events surveillance data
Context-sensitive network analysis identifies food metabolites associated with Alzheimer’s disease: an exploratory study
Data-driven multiple-level analysis of gut-microbiome-immune-joint interactions in rheumatoid arthritis
Large-scale combining signals from both biomedical literature and the FDA Adverse Event Reporting System (FAERS) to improve post-marketing drug safety signal detection
Towards understanding brain-gut-microbiome connections in Alzheimer’s disease
Mining comorbidities of opioid use disorder from FDA adverse event reporting system and patient electronic health records
Large-scale extraction of accurate drug-disease treatment pairs from biomedical literature for drug repurposing
The horizontal-to-vertical spectral ratio and its applications
Phenome-based gene discovery provides information about Parkinson’s disease drug targets
MiR-421 Is Overexpressed and Promotes Cell Proliferation in Non-Small Cell Lung Cancer
Identification of hub genes and establishment of a diagnostic model in tuberculosis infection
A genomics-based systems approach towards drug repositioning for rheumatoid arthritis
Large-scale mining disease comorbidity relationships from post-market drug adverse events surveillance data
Context-sensitive network analysis identifies food metabolites associated with Alzheimer’s disease: an exploratory study
Data-driven multiple-level analysis of gut-microbiome-immune-joint interactions in rheumatoid arthritis
Large-scale combining signals from both biomedical literature and the FDA Adverse Event Reporting System (FAERS) to improve post-marketing drug safety signal detection
Towards understanding brain-gut-microbiome connections in Alzheimer’s disease
Mining comorbidities of opioid use disorder from FDA adverse event reporting system and patient electronic health records
Large-scale extraction of accurate drug-disease treatment pairs from biomedical literature for drug repurposing
The horizontal-to-vertical spectral ratio and its applications
Phenome-based gene discovery provides information about Parkinson’s disease drug targets
MiR-421 Is Overexpressed and Promotes Cell Proliferation in Non-Small Cell Lung Cancer
Identification of hub genes and establishment of a diagnostic model in tuberculosis infection
A genomics-based systems approach towards drug repositioning for rheumatoid arthritis
Large-scale mining disease comorbidity relationships from post-market drug adverse events surveillance data
Context-sensitive network analysis identifies food metabolites associated with Alzheimer’s disease: an exploratory study
Data-driven multiple-level analysis of gut-microbiome-immune-joint interactions in rheumatoid arthritis
Large-scale combining signals from both biomedical literature and the FDA Adverse Event Reporting System (FAERS) to improve post-marketing drug safety signal detection
Towards understanding brain-gut-microbiome connections in Alzheimer’s disease
Mining comorbidities of opioid use disorder from FDA adverse event reporting system and patient electronic health records
Large-scale extraction of accurate drug-disease treatment pairs from biomedical literature for drug repurposing
The horizontal-to-vertical spectral ratio and its applications
Phenome-based gene discovery provides information about Parkinson’s disease drug targets
MiR-421 Is Overexpressed and Promotes Cell Proliferation in Non-Small Cell Lung Cancer